Expression and prognostic implications of cell cycle regulatory molecules, p16, p21, p27, p14 and p53 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas.
about
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkersTreatment of diffuse large B cell lymphomaA Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma.P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma.No Prognostic Impact of p53 and P-Glycoprotein Expression in Patients with Diffuse Large B-Cell Lymphoma.Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma.EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations.Clinicopathologic implications of the miR-197/PD-L1 axis in oral squamous cell carcinomaThe status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progression.Thymic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: a gene methylation study.Cell cycle regulation score predicts relapse-free survival in non-germinal centre diffuse large B-cell lymphoma patients treated by means of immunochemotherapy.Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large B-cell lymphomas.
P2860
Q24646379-D1AFA8A6-B31D-4DA9-8190-61A9060CF449Q27006062-CE60FB4F-0BAD-4382-8E45-13386D27D583Q35930640-B086B062-507D-4E99-81A0-AB10A8CF192CQ36776444-52478EC5-DA2E-4C14-8CFF-73A6B71C8CECQ39292664-C5806C73-DFB5-4A99-9BF5-626C03D4412CQ40235799-8C28428B-EDA7-48A9-B4AF-738A4031466BQ41211534-962B3C04-AB1C-4899-B384-90A69386B84BQ42051829-1FEF5D7F-0D77-453B-A4A4-DE809E62F8BDQ42371619-B1101C7B-3D00-4ABA-AABF-C762DB60B762Q43199707-5E697955-9A6C-458F-95FF-0902ABD044EDQ43410475-6035EF3C-31AB-4592-936A-8A93D4E6C6B2Q51235143-8ABC7D49-7C6A-4AFA-BEBA-7645D2F6D3D6Q54585310-BCB3065C-E8B0-4470-8F96-BF6F746BDFC6
P2860
Expression and prognostic implications of cell cycle regulatory molecules, p16, p21, p27, p14 and p53 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Expression and prognostic impl ...... iffuse large B-cell lymphomas.
@en
Expression and prognostic impl ...... iffuse large B-cell lymphomas.
@nl
type
label
Expression and prognostic impl ...... iffuse large B-cell lymphomas.
@en
Expression and prognostic impl ...... iffuse large B-cell lymphomas.
@nl
prefLabel
Expression and prognostic impl ...... iffuse large B-cell lymphomas.
@en
Expression and prognostic impl ...... iffuse large B-cell lymphomas.
@nl
P2093
P2860
P1433
P1476
Expression and prognostic impl ...... iffuse large B-cell lymphomas.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2559.2005.02222.X
P577
2005-09-01T00:00:00Z